2023
DOI: 10.1016/j.ejmech.2022.115008
|View full text |Cite
|
Sign up to set email alerts
|

Isoform selectivities of novel 4-hydroxycoumarin imines as inhibitors of myosin II

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2024
2024
2024
2024

Publication Types

Select...
3
1

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(2 citation statements)
references
References 62 publications
0
2
0
Order By: Relevance
“…The inhibition of muscle myosin is of interest to develop therapeutic agents for the treatment of hypercontractile states. On this ground, Bell and others designed novel 4-hydroxycoumarin imines as muscle myosin II inhibitors ( Smith et al, 2023 ). Among the synthesized derivatives, compound 226 ( Figure 7 ) showed the highest selectivity towards skeletal myosin (IC 50 = 3.3 μM) over the cardiac and smooth muscle isoforms (IC 50 > 100 μM).…”
Section: Biological Applications Of Coumarin Derivativesmentioning
confidence: 99%
“…The inhibition of muscle myosin is of interest to develop therapeutic agents for the treatment of hypercontractile states. On this ground, Bell and others designed novel 4-hydroxycoumarin imines as muscle myosin II inhibitors ( Smith et al, 2023 ). Among the synthesized derivatives, compound 226 ( Figure 7 ) showed the highest selectivity towards skeletal myosin (IC 50 = 3.3 μM) over the cardiac and smooth muscle isoforms (IC 50 > 100 μM).…”
Section: Biological Applications Of Coumarin Derivativesmentioning
confidence: 99%
“…Primarily, 4-hydroxycoumarin contains hydroxyl group at the 4-position, and 4hydroxycoumarin derivatives have shown an amazingly broad spectrum of pharmacological and physiological activities, and they are employed as the anti-inflammatory agents(Y. Yang et al 2023), anticoagulant (Abdelhafez et al 2010), antimicrobial(Belkhir-Talbi et al 2021, antibacterial (Patel et al 2013), antioxidant (Guerrero et al 2021), Muscle myosin II inhibitor(J. D. Smith et al 2023), antifungal (Chohan et al 2006), anti-HIV (Hassan et al 2016), antitumor(Z. Chen, Bi, and Su 2013), anti-cancer(X.-Q. Wang et al 2020), insecticidal(M. Wang et al 2009), p38 Mitogen-Activated Protein Kinase inhibitor (Wu et al 2023) and tyrosine kinase inhibitor(E. B.…”
Section: Introductionmentioning
confidence: 99%